Dachaigh › Luchd-obrach › Dualitybio Inc.
Dualitybio Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Dualitybio Inc. 9 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 9. Tuarastal meadhanach a chaidh a thabhann: $83,302.
A bheil Dualitybio Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Dualitybio Inc. 9 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 23 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Associate Director, Clinical Pharmacology | 3 | $210,000 |
| Senior Clinical Research Associate I | 2 | $68,784 |
| Clinical Research Associate II | 1 | $63,000 |
| Clinical Research Associate | 1 | — |
| Epidemiology Research Associate | 1 | $75,764 |
| Clinical Research Associate (senior) | 1 | $90,840 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $131,500 |
| FY2024 | 2 | $210,000 |
| FY2025 | 3 | $68,784 |
| FY2026 | 1 | $90,840 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Clinical Research Associate (senior) | $90,840 Ìre I | Silver Spring, MD | 23 Ògmh 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Clinical Research Associate I | $68,784 Ìre I | Sugar Land, TX | 2 Sult 2025 | 22 Gearr 2026 | Dearbhaichte |
| Senior Clinical Research Associate I | $68,784 Ìre I | Sugar Land, TX | 25 Lùna 2025 | 22 Gearr 2026 | Dearbhaichte |
| Epidemiology Research Associate | $75,764 Ìre I | Jersey City, NJ | 11 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Associate Director, Clinical Pharmacology | $210,000 Ìre IV | Cambridge, MA | 19 Ògmh 2024 | 19 Ògmh 2024 | Dearbhaichte |
| Associate Director, Clinical Pharmacology | $210,000 Ìre IV | Cambridge, MA | 10 Ògmh 2024 | 19 Iuch 2024 | Dearbhaichte |
| Clinical Research Associate | $74,173 pàirt-àm · Ìre I | Silver Spring, MD | 15 Lùna 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Associate Director, Clinical Pharmacology | $200,000 Ìre IV | Northbrook, IL | 27 Ògmh 2023 | 7 Iuch 2023 | Dearbhaichte |
| Clinical Research Associate II | $63,000 Ìre I | Houston, TX | 10 Gearr 2023 | 22 Gearr 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).